Edition:
United States

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

9.10USD
21 Sep 2018
Change (% chg)

$0.60 (+7.06%)
Prev Close
$8.50
Open
$8.45
Day's High
$9.55
Day's Low
$8.20
Volume
130,566
Avg. Vol
28,665
52-wk High
$9.55
52-wk Low
$5.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.458
Mar '18 0.00 -0.434
FY 2017 Dec '17 0.00 -0.363
Sep '17 0.00 -0.320
Jun '17 0.00 -0.351
Mar '17 0.00 -0.369
FY 2016 Dec '16 0.00 -0.370
Sep '16 0.00 -0.383
Jun '16 0.00 -0.405
Mar '16 0.00 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 7 0.04 0.28 0.00 4.22
Earnings (per share)
Quarter Ending Sep-18 6 -0.46 -0.41 -0.50 -0.50
Quarter Ending Dec-18 6 -0.43 -0.39 -0.47 -0.51
Year Ending Dec-18 6 -1.78 -1.74 -1.86 -1.97
Year Ending Dec-19 7 -1.93 -1.33 -3.89 -2.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta 0.59 0.61 0.87
Price to Sales (TTM) -- 110.30 6.46
Price to Book (MRQ) 5.13 12.48 3.90
Price to Tangible Book (MRQ) 5.16 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -30.58 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -6.96 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 8.11 5.49 2.97
LT Debt to Equity (MRQ) 2.69 15.10 11.24
Total Debt to Equity (MRQ) 3.64 18.62 14.06
Interest Coverage (TTM) -- -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -- -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -- -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -- -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,335,375 714,979,821
Net Income/Employee (TTM) -- -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -84.26 0.80 9.75
Return on Assets - 5 Yr. Avg. -50.85 2.53 10.91
Return on Investment (TTM) -94.30 1.50 12.72
Return on Investment - 5 Yr. Avg. -56.02 2.04 14.03
Return on Equity (TTM) -97.44 0.19 14.85
Return on Equity - 5 Yr. Avg. -1,184.70 -2.23 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 14.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aldeyra Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.69%
# of Holders: 92
Total Shares Held: 15,665,371
3 Mo. Net Change: 1,677,051
# New Positions: 36
# Closed Positions: 7
# Increased Positions: 63
# Reduced Positions: 16
# Net Buyers: 47
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.